Evidence map›Paper›PMID 42626168›Full record

ArticleCase reports in rheumatology2026

A Case of Critical Digit Ischemia in a Patient With Suspected Seronegative Scleroderma Diagnosed via Nailfold Capillaroscopy.

Matthew Kornas, Charis Wang, Sehreen Mumtaz, Adrian G Dumitrascu, Florentina Berianu

Abstract read
In one paragraph

Article in Case reports in rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Matthew KornasDepartment of Internal Medicine, Division of Hospital Internal Medicine, Mayo Clinic, Jacksonville, Florida, USA, mayo.edu.ORCID https://orcid.org/0009-0002-0180-3262
Charis WangAlix School of Medicine, Mayo Clinic, Phoenix, Arizona, USA, mayo.edu.ORCID https://orcid.org/0000-0003-4933-5533
Sehreen MumtazDepartment of Internal Medicine, Division of Rheumatology, Mayo Clinic, Jacksonville, Florida, USA, mayo.edu.ORCID https://orcid.org/0000-0002-1015-1633
Adrian G DumitrascuDepartment of Internal Medicine, Division of Hospital Internal Medicine, Mayo Clinic, Jacksonville, Florida, USA, mayo.edu.ORCID https://orcid.org/0000-0003-1557-9791
Florentina BerianuDepartment of Internal Medicine, Division of Rheumatology, Mayo Clinic, Jacksonville, Florida, USA, mayo.edu.ORCID https://orcid.org/0000-0001-8370-9178

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systemic sclerosis (scleroderma) can manifest with advanced symptoms of ischemic vasculopathy, including digital ulcer development. These ulcerations can be disabling and detrimental to a patient's quality of life, so prompt diagnosis, differentiation from other vascular etiologies, and treatment are important to help salvage this tissue. However, diagnosis of scleroderma can be challenging in the setting of seronegative disease. Nailfold capillaroscopy is a vital tool that can assist with diagnosis in seronegative cases. Scleroderma pattern findings on nailfold capillaroscopy include dilated or giant capillaries, capillary hemorrhages, and dropouts. Pharmacologic and surgical modalities can effectively treat vascular complications from scleroderma. Vasodilation therapy with prostacyclin analogs, calcium channel blockers, or angiotensin II receptor blockers can improve ischemic tissue perfusion. Surgical sympathectomy should be offered to treat ulcerative tissue and improve related pain control. We present a case of seronegative scleroderma in a patient with digital ischemic ulcerations that was expediently diagnosed and treated with assistance of nailfold capillaroscopy.

Identifiers

PMID42626168
PMCPMC13490826

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.